These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2650183)

  • 1. Donor bone marrow cell induced prolongation of murine cardiac allografts.
    Hoshinaga K; Mohanakumar T; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):491-3. PubMed ID: 2650183
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
    Gozzo JJ; Kowolenko M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
    De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
    Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatally induced transplantation tolerance to primarily vascularised cardiac allografts is not donor-specific.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):184-5. PubMed ID: 7878966
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
    De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
    Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
    [No Abstract]   [Full Text] [Related]  

  • 7. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 8. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 9. Cloned veto cells as immunoregulators.
    Takeda Y; Yanagie H; Maki T
    Transplant Proc; 1993 Aug; 25(4):2743-4. PubMed ID: 8356732
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of the activity of graft survival-prolonging bone marrow cells.
    Gozzo JJ; Monaco AP; De Fazio SR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):271-2. PubMed ID: 2650117
    [No Abstract]   [Full Text] [Related]  

  • 11. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
    Guo C; Dai K; Tang T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microchimerism does not correlate with survival of murine cardiac allografts.
    de Moraes LV; Bueno V; Panajotopoulos N; Rizzo LV
    Transplant Proc; 2004 May; 36(4):1021-2. PubMed ID: 15194355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative bone marrow injections with cyclosporine or antithymocyte globulin in rat cardiac allografts.
    Thomas WG; Sadeghi AM; Kurlansky P; Michler RE; Smith CR; Reemtsma K; Rose EA
    Transplantation; 1986 Oct; 42(4):441-2. PubMed ID: 3532457
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 17. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
    J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal induction of tolerance to cardiac allografts.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1994 Feb; 26(1):207-8. PubMed ID: 8108945
    [No Abstract]   [Full Text] [Related]  

  • 19. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.